may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful https://oakley-sunglassesformen.us/Wiuff-mother-of-Luckenbaugh-from-Drumbilla?Meylorbro=106
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..